International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.12787843
Original Research Article
Invasive Sino-Orbital Aspergillosis: A Case Report and Comprehensive Review of Literature
Published
Dec. 12, 2024
Abstract

Invasive aspergillosis of the paranasal sinuses represents a life-threatening opportunistic infection that predominantly affects immunocompromised patients. Despite advances in medical therapy, it remains a significant cause of morbidity and mortality, particularly when orbital involvement occurs. We present a detailed case analysis and comprehensive literature review of invasive sino-orbital aspergillosis, focusing on diagnostic approaches, treatment modalities, and outcome measures. A 62- year-old female with poorly controlled diabetes mellitus presented with right maxillary pain and swelling, complicated by sixth and seventh cranial nerve involvement. Through systematic diagnostic evaluation including radiological imaging, surgical intervention, and histopathological analysis, invasive sino-orbital aspergillosis was confirmed. The patient underwent successful treatment with a combination of intravenous Liposomal Amphotericin B, oral Posaconazole, and surgical debridement via Functional Endoscopic Sinus Surgery (FESS). Following aggressive medical and surgical intervention, the patient achieved complete resolution of infection with no evidence of recurrence during the follow-up period. This case emphasizes the importance of early diagnosis and aggressive treatment in managing invasive sinoorbital aspergillosis.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
2495 Views
337 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved